S&P 500
(0.18%) 5 317.78 points
Dow Jones
(0.23%) 39 998 points
Nasdaq
(0.14%) 16 766 points
Oil
(0.92%) $79.35
Gas
(2.86%) $2.49
Gold
(-0.46%) $2 384.00
Silver
(0.46%) $29.87
Platinum
(-0.39%) $1 065.90
USD/EUR
(0.12%) $0.920
USD/NOK
(0.25%) $10.69
USD/GBP
(0.06%) $0.789
USD/RUB
(0.25%) $90.91

Realtime updates for Biophytis SA American [BPTS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated25 Apr 2024 @ 16:00

0.00% 8.22

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):
Profile picture for Biophytis SA American Depositary Share

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases...

Stats
Today's Volume 17 954.00
Average Volume 9 664.00
Market Cap 2.61M
EPS €0 ( 2024-04-16 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -0.0600
ATR14 €0.356 (4.07%)

Biophytis SA American Correlation

10 Most Positive Correlations
SERA0.952
DCFC0.951
NVTS0.939
ADPT0.937
BAOS0.934
BOXL0.933
LEXX0.932
PACB0.932
AEHR0.931
WOOF0.929
10 Most Negative Correlations
ENNVU-0.975
ENVI-0.954
MCAA-0.945
BCOR-0.943
KVSC-0.943
MSAC-0.94
SVFA-0.937
TZPS-0.937
SPLK-0.935
JUGG-0.933

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biophytis SA American Financials

Annual 2023
Revenue: €0
Gross Profit: €-803 000 (0.00 %)
EPS: €-0.0314
FY 2023
Revenue: €0
Gross Profit: €-803 000 (0.00 %)
EPS: €-0.0314
FY 2022
Revenue: €0
Gross Profit: €-484 000 (0.00 %)
EPS: €-0.130
FY 2021
Revenue: €0.00
Gross Profit: €0.00 (0.00 %)
EPS: €-2.60

Financial Reports:

No articles found.

Biophytis SA American Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Biophytis SA American

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators